Senior Investment Manager, Oost NL
At Oost NL Capital, Viktor is responsible for acquiring, managing and exiting investments across all life sciences areas with an emphasis on medtech. He was amongst others closely involved in the investments in NovioGendix (sold to MDxHealth), Lead Pharma and Mellon Medical. He currently serves as a board observer for Mellon Medical, Encapson, Check-Points, Sigmascreening, Soteria Medical and Gatt Technologies. Viktor has more than 15 years of experience in venture capital. At first as investment officer at Triodos Venture Capital Fund and from 2005 as senior investment manager at Oost NL Capital. He has a background in engineering (MSc. TU Delft) and business administration (MBA, UC Berkeley).
Oost NL Capital is a regional venture capital company that is part of East Netherlands Development Agency (Oost NL). Oost NL Capital administers government funds and manages revolving regional venture capital funds for specific sectors in the provinces Gelderland and Overijssel. With a fund volume of more than € 350 million Oost NL Capital is involved in more than 230 companies and funds.